ERT works by providing the patient with a recombinant form of the deficient enzyme. For example, in Pompe Disease, a recombinant form of the enzyme acid alpha-glucosidase is administered to help break down glycogen. This treatment helps reduce the build-up of harmful substances, alleviating symptoms and improving overall function.